ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 908 • 2012 ACR/ARHP Annual Meeting

    Race, Gender and Total Knee Replacement Consideration: The Role of Social Support

    Ernest R. Vina1, Yona Cloonan2, Said Ibrahim3, Michael J. Hannon4, Robert M. Boudreau5 and C. Kent Kwoh6, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh and VA Healthcare System, Pittsburgh, PA, 2Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, 3Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 4Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 5Epidemiology, University of Pittsburgh, Pittsburgh, PA, 6School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: There is marked variation in patient preference (i.e. willingness) regarding total knee replacement (TKR), an effective treatment option for end-stage osteoarthritis (OA).  Studies have…
  • Abstract Number: 909 • 2012 ACR/ARHP Annual Meeting

    Determinants of Patient Preferences for Total Knee Replacement: A Comparison of Whites and African-Americans

    C. Kent Kwoh1, Robert M. Boudreau2, Yona Cloonan3, Michael J. Hannon4, Ernest R. Vina5 and Said Ibrahim6, 1School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Epidemiology, University of Pittsburgh, Pittsburgh, PA, 3Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, 4Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 5Division of Rheumatology and Clinical Immunology, University of Pittsburgh and VA Pittsburgh Healthcare System, Pittsburgh, PA, 6Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

    Background/Purpose: TKR is a cost-effective treatment option for end-stage knee osteoarthritis (OA). Although it is one of the fastest growing elective surgeries, there are marked…
  • Abstract Number: 910 • 2012 ACR/ARHP Annual Meeting

    The Cost-Effectiveness of Total Joint Arthroplasty: A Systematic Review of Published Literature

    Meghan E. Daigle1, Alexander M. Weinstein1, Jeffrey N. Katz2 and Elena Losina1, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Utilization of total hip arthroplasty (THA) and total knee arthroplasty (TKA) has nearly doubled in the last decade.  These procedures are increasingly performed in…
  • Abstract Number: 911 • 2012 ACR/ARHP Annual Meeting

    Race- and Sex-Specific Estimates of 10-, 20-, 30-Year, and Lifetime Risk of Diagnosed Symptomatic Knee Osteoarthritis and the Need for TKR in the US

    Elena Losina1, Meghan E. Daigle1, Sara A. Burbine1 and Jeffrey N. Katz2, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: A growing body of evidence suggests that females are more likely to be diagnosed with knee osteoarthritis (OA) and that obesity increases the risk…
  • Abstract Number: 912 • 2012 ACR/ARHP Annual Meeting

    Clinical Features Associated with Progression of Knee Radiographic Osteoarthritis: Data From the Osteoarthritis Initiative

    Michelle S. Yau1, Laura Yerges-Armstrong1, Braxton D. Mitchell1 and Marc C. Hochberg2, 1Departments of Medicine and Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD, 2Department of Medicine, University of Maryland, Baltimore, MD

    Background/Purpose:  A better understanding of the factors associated with structural progression of knee osteoarthritis (OA) may help identify individuals not only at risk for more…
  • Abstract Number: 913 • 2012 ACR/ARHP Annual Meeting

    Consultation Prevalence of Osteoarthritis in Southern Sweden

    Aleksandra Turkiewicz1, Ingemar F. Petersson2, Jonas Björk3, Leif E. Dahlberg1 and Martin Englund1, 1Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden, 2Lund University, Lund, Sweden, 3Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden, Lund, Sweden

    Background/Purpose: To estimate the prevalence of subjects with osteoarthritis (OA) having led to doctor consultation. Methods: The Skåne Health Care Register (SHCR) is a legislative,…
  • Abstract Number: 873 • 2012 ACR/ARHP Annual Meeting

    Imbalance Between Histone Acetyl Transferase and Histone Deacteylase Activities and Modulation of HDAC Activity and Tnfa Production by HDAC Inhibitors in Patients with Ankylosing Spondylitis or Rheumatoid Arthritis

    Eric Toussirot1, Wasim Abbas2, Kashif Aziz Khan3, Marion Tissot4, Alicia Jeudy2, Lucile Baud2, Ewa Bertolini5, Daniel Wendling6, Georges Herbein7 and CIC Biotherapy8, 1Université de Franche Comté , CHRU, CIC Biotherapy 506 and Rheumatology and EA 4266 Pathogens and Inflammation, Besançon, France, 2University of Franche Comté, EA 4266 Pathogens and Inflammation, Besançon, France, 3University of Franche Comté, EA Pathogens and Inflammation, Besançon, France, 4EA Pathogens and Inflammation, EA 4266 Pathogens and Inflammation, Besançon, France, 5University Hospital, Rheumatology, Besançon, France, 6Service de Rhumatologie, Minjoz University Hospital, Besancon, France, 7University Hospital, Virology and EA 4266 Pathogens and Inflamamtion, Besançon, France, 8University Hospital, Besançon, France

    Background/Purpose: TNFa is a major cytokine involved in conditions such as ankylosing spondylitis (AS) and rheumatoid arthritis (RA). Epigenetic regulation corresponds to different processes including…
  • Abstract Number: 874 • 2012 ACR/ARHP Annual Meeting

    TNFα Induces Sustained Signaling and a Prolonged and Unremitting Inflammatory Response in Synovial Fibroblasts

    Angela Lee1, Galina Grigoriev1, Janice Chen1, Lionel B. Ivashkiv2 and George D. Kalliolias1, 1Medicine, Hospital for Special Surgery, New York, NY, 2Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: The non resolving character of synovial inflammation in rheumatoid arthritis (RA) is a conundrum. To identify the contribution of fibroblast-like synoviocytes (FLS) to the…
  • Abstract Number: 875 • 2012 ACR/ARHP Annual Meeting

    Discovery of Pharmacologic MIF Antagonists by Structure-Based Molecular Design

    William L. Jorgensen1, Alissa A. Hare1, Zoe Cournia1, Sunilkumar Gandavadi1, Xin Du1, Lin Leng1 and Richard J. Bucala2, 1Yale University, New Haven, CT, 2Rheum/Dept of Int Med, Yale University School of Med, New Haven, CT

    Background/Purpose: Cytokine inhibition is becoming a mainstay for the therapy of autoimmunity but current antibody-based approaches remain limited by high cost, parenteral administration, and anti-idiotype…
  • Abstract Number: 876 • 2012 ACR/ARHP Annual Meeting

    Xanthine Oxidase-Derived ROS Direct Context-Dependent Action of NFAT5 Toward Inflammatory Response in Macrophages

    Nam Hoon Kim, Research Institute of Immunobiology, Catholic university of Korea, Seoul of Korea, Seoul, South Korea

    Background/Purpose: NFAT5, a well known osmo-protective factor, can be activated by isotonic stimuli, such as Toll-like receptor (TLR) triggering. Here, we identified a novel signal…
  • Abstract Number: 877 • 2012 ACR/ARHP Annual Meeting

    Aberrant Expression of BAFF Receptor (BR3) in Peripheral Monocytes of Patients with Primary Sjögren’s Syndrome Impacts Abnormal Activation of BAFF Signaling Through IKK-Alphaand IKK-Beta

    Keiko Yoshimoto1, Maiko Tanaka2, Masako Kojima2, Hideko Ogata2, Hideto Kameda1, Katsuya Suzuki1, Tohru Abe3 and Tsutomu Takeuchi4, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 2Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 3Dept Int Med Saitama Med Ctr, Saitama Medical School, Kawagoe-shi Saitama, Japan, 4Rheumatology, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose: B cell activating factor belonging to the TNF superfamily (BAFF) regulates proliferation, differentiation and survival of B cells and plays a pivotal role in…
  • Abstract Number: 878 • 2012 ACR/ARHP Annual Meeting

    Differential Regulation of Cytokines by Extracellular-Signal Regulated Kinase and c-Jun N-Terminal Kinase in Map Kinase Kinase-3 and -6 Deficiency

    Deepa Hammaker1, Katharyn Topolewski2, Monica Guma3, David L. Boyle4 and Gary S. Firestein5, 1MC 0656, UCSD School of Medicine, La Jolla, CA, 2UCSD School of Medicine, La Jolla, CA, 3Rheumatology, UCSD School of Medicine, La Jolla, CA, 4Div of Rheum, UCSD School of Medicine, La Jolla, CA, 5Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose:   p38 inhibitors have limited efficacy in rheumatoid arthritis (RA), possibly because p38 blockade suppresses IL-10 production and increases JNK and ERK phosphorylation in…
  • Abstract Number: 879 • 2012 ACR/ARHP Annual Meeting

    Fucosyltransferase 1 (fut1) Is Overexpressed in Rheumatoid Arthritis Synovial Tissue and Modifies Cytokine Production

    Takeo Isozaki1, Jeffrey H. Ruth2, M. Asif Amin1, Phillip L. Campbell1, Steven E. Domino3, G. Kenneth Haines III4 and Alisa E. Koch5, 1Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 2Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 3Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, 4Department of Pathology, Yale University, New Haven, CT, 5Internal Medicine - Rheumatology, University of Michigan Medical School, Ann Arbor, MI

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction. Angiogenesis and cytokine production are involved in the pathogenesis of…
  • Abstract Number: 880 • 2012 ACR/ARHP Annual Meeting

    Interferon Regulatory Factor 8 Regulates BAFF Production in Murine Macrophages and Is a Nexus for Cross Talk Between IFN-γ and TGF-β

    Weijia Yuan1, Sanjay Gupta2, Jane E. Salmon3 and Alessandra B. Pernis2, 1Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 2Autoimmunity & Inflammation, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 3Dept of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY

    Background/Purpose: Lupus is a systemic autoimmune disease that can lead to severe end-organ damage characterized by unabated inflammation and aberrant tissue repair. Macrophage dysregulation plays…
  • Abstract Number: 881 • 2012 ACR/ARHP Annual Meeting

    Microrna-155 Regulates Chemokines and Chemokine Receptors in Rheumatoid Arthritis Monocyte

    Aziza Elmesmari1, Derek S. Gilchrist1, Alasdair R. Fraser1, Diane Vaughan1, Ross McQueenie2, Gerard J. Graham1, James Brewer3, Iain B. McInnes1 and Mariola Kurowska-Stolarska1, 1Immunology, Institute of Infection,Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 2Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 3Immunology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose:   Rheumatoid arthritis (RA) is characterized by synovial tissue inflammation leading to joint destruction. Monocytes/macrophages are major effector cells in RA synovitis, principally by releasing…
  • « Previous Page
  • 1
  • …
  • 2360
  • 2361
  • 2362
  • 2363
  • 2364
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology